Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders.

Clinical evidence suggests comorbidity between depression and irritable bowel syndrome (IBS). Early-life stress and genetic predisposition are key factors in the pathophysiology of both IBS and depression. Thus, neonatal maternal separation (MS), and the Wistar-Kyoto (WKY) rat, a genetically stress-sensitive rat strain, are two animal models of depression that display increased visceral hypersensitivity and alterations in the hypothalamic-pituitary-adrenal axis. Corticotrophin-releasing factor (CRF) is the primary peptide regulating this axis, acting through two receptors: CRF1 and CRF2. The central CRF system is also a key regulator in the stress response. However, there is a paucity of studies investigating alterations in the central CRF system of adult MS or WKY animals. Using in-situ hybridization we demonstrate that CRF mRNA is increased in the paraventricular nucleus (PVN) of WKY rats and the dorsal raphé nucleus (DRN) of MS animals, compared to Sprague-Dawley and non-separated controls, respectively. Additionally, CRF1 mRNA was higher in the PVN, amygdala and DRN of both animal models, along with high levels of CRF1 mRNA in the hippocampus of WKY animals compared to control animals. Finally, CRF2 mRNA was lower in the DRN of MS and WKY rats compared to control animals, and in the hippocampus and amygdala of MS rats. These results show that the central CRF system is altered in both animal models. Such alterations may affect HPA axis regulation, contribute to behavioural changes associated with stress-related disorders, and alter the affective component of visceral pain modulation, which is enhanced in IBS patients.

[1]  C. Pariante,et al.  The glucocorticoid receptor: Pivot of depression and of antidepressant treatment? , 2011, Psychoneuroendocrinology.

[2]  T. Dinan,et al.  Neonatal maternal separation in the rat impacts on the stress responsivity of central corticotropin-releasing factor receptors in adulthood , 2011, Psychopharmacology.

[3]  T. Dinan,et al.  Alterations in colonic corticotropin-releasing factor receptors in the maternally separated rat model of irritable bowel syndrome: Differential effects of acute psychological and physical stressors , 2010, Peptides.

[4]  J. Cryan,et al.  Differential stress‐induced alterations of colonic corticotropin‐releasing factor receptors in the Wistar Kyoto rat , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[5]  T. Dinan,et al.  Distinct alterations in colonic morphology and physiology in two rat models of enhanced stress-induced anxiety and depression-like behaviour , 2010, Stress.

[6]  J. Cryan,et al.  Colorectal distension-induced prefrontal cortex activation in the Wistar–Kyoto rat: implications for irritable bowel syndrome , 2010, Neuroscience.

[7]  T. Dinan,et al.  5‐HT2B receptors modulate visceral hypersensitivity in a stress‐sensitive animal model of brain‐gut axis dysfunction , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[8]  T. Dinan,et al.  Toll-Like Receptor mRNA Expression Is Selectively Increased in the Colonic Mucosa of Two Animal Models Relevant to Irritable Bowel Syndrome , 2009, PloS one.

[9]  J. Devin McAuley,et al.  Wistar–Kyoto rats as an animal model of anxiety vulnerability: Support for a hypervigilance hypothesis , 2009, Behavioural Brain Research.

[10]  T. Dinan,et al.  Irritable bowel syndrome: towards biomarker identification. , 2009, Trends in molecular medicine.

[11]  Y. Taché,et al.  A role for corticotropin-releasing factor in functional gastrointestinal disorders , 2009, Current gastroenterology reports.

[12]  J. Cryan,et al.  A distinct subset of submucosal mast cells undergoes hyperplasia following neonatal maternal separation: a role in visceral hypersensitivity? , 2009, Gut.

[13]  P. Morales,et al.  Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection , 2009, Behavioural pharmacology.

[14]  D. O'Malley,et al.  Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression , 2009, Neuroscience.

[15]  M. Antony,et al.  Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression. , 2009, Journal of anxiety disorders.

[16]  M. Yoshioka,et al.  Role of enhanced noradrenergic transmission within the ventral bed nucleus of the stria terminalis in visceral pain-induced aversion in rats , 2009, Behavioural Brain Research.

[17]  P. Scully,et al.  Early Life Stress Alters Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and Psychiatric Illnesses , 2009, Biological Psychiatry.

[18]  Y. Taché,et al.  From Hans Selye's Discovery of Biological Stress to the Identification of Corticotropin‐ Releasing Factor Signaling Pathways , 2008, Annals of the New York Academy of Sciences.

[19]  C. Large,et al.  Chronic stress‐induced alterations in amygdala responsiveness and behavior – modulation by trait anxiety and corticotropin‐releasing factor systems , 2008, The European journal of neuroscience.

[20]  J. Herman,et al.  The Role of the Forebrain Glucocorticoid Receptor in Acute and Chronic Stress , 2022 .

[21]  C. Large,et al.  CRF1 Receptor Activation Increases the Response of Neurons in the Basolateral Nucleus of the Amygdala to Afferent Stimulation , 2008, Frontiers in behavioral neuroscience.

[22]  T. Dinan,et al.  Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[23]  L. Desbonnet,et al.  Sexually dimorphic effects of maternal separation stress on corticotrophin-releasing factor and vasopressin systems in the adult rat brain , 2008, International Journal of Developmental Neuroscience.

[24]  V. Neugebauer,et al.  Differential Mechanisms of CRF1 and CRF2 Receptor Functions in the Amygdala in Pain-Related Synaptic Facilitation and Behavior , 2008, The Journal of Neuroscience.

[25]  Adrián Martínez,et al.  Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety , 2008, Psychoneuroendocrinology.

[26]  C. H. Summers,et al.  Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens. , 2008, European journal of pharmacology.

[27]  Christoph Schmitz,et al.  The dorsal raphe nucleus—From silver stainings to a role in depression , 2007, Brain Research Reviews.

[28]  F. Barreau,et al.  New Insights in the Etiology and Pathophysiology of Irritable Bowel Syndrome: Contribution of Neonatal Stress Models , 2007, Pediatric Research.

[29]  C. Nemeroff,et al.  Long‐term behavioural and molecular alterations associated with maternal separation in rats , 2007, The European journal of neuroscience.

[30]  W. Leung,et al.  Effects of neonatal maternal separation on neurochemical and sensory response to colonic distension in a rat model of irritable bowel syndrome. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[31]  W. Vale,et al.  The Effect of Lateral Septum Corticotropin-Releasing Factor Receptor 2 Activation on Anxiety Is Modulated by Stress , 2006, The Journal of Neuroscience.

[32]  P. Morales,et al.  Adrenalectomy promotes a permanent decrease of plasma corticoid levels and a transient increase of apoptosis and the expression of Transforming Growth Factor β1 (TGF-β1) in hippocampus: effect of a TGF-β1 oligo-antisense , 2006, BMC Neuroscience.

[33]  E. Benarroch,et al.  Pain-autonomic interactions , 2006, Neurological Sciences.

[34]  C. Lowry,et al.  Regulation of behavioral responses by corticotropin-releasing factor. , 2006, General and comparative endocrinology.

[35]  I. Lucki,et al.  Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test , 2005, Neuroscience & Biobehavioral Reviews.

[36]  C. Nemeroff,et al.  Long-Term Consequences of Neonatal Rearing on Central Corticotropin-Releasing Factor Systems in Adult Male Rat Offspring , 2005, Neuropsychopharmacology.

[37]  C. L. Kwan,et al.  Abnormal forebrain activity in functional bowel disorder patients with chronic pain , 2005, Neurology.

[38]  C. Flachskamm,et al.  Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin‐releasing factor receptor type 1 and type 2 agonists , 2005, Journal of neurochemistry.

[39]  K. Gysling,et al.  Adrenalectomy decreases corticotropin‐releasing hormone gene expression and increases noradrenaline and dopamine extracellular levels in the rat lateral bed nucleus of the stria terminalis , 2005, Journal of neuroscience research.

[40]  J. Schulkin,et al.  Corticotropin‐releasing factor 1 receptor‐mediated mechanisms inhibit colonic hypersensitivity in rats , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[41]  F. Holsboer,et al.  Stress and the brain: from adaptation to disease , 2005, Nature Reviews Neuroscience.

[42]  K. Short,et al.  A stress-induced anxious state in male rats: Corticotropin-releasing hormone induces persistent changes in associative learning and startle reactivity , 2005, Biological Psychiatry.

[43]  T. Bolwig,et al.  Maternal separation affects male rat copulatory behaviour and hypothalamic corticotropin releasing factor in concert , 2005, Behavioural Brain Research.

[44]  R. Valentino,et al.  Peptides that fine-tune the serotonin system , 2005, Neuropeptides.

[45]  J. Tsien,et al.  Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Lawrence,et al.  Prepulse inhibition in fawn-hooded rats: increased sensitivity to 5-HT1A receptor stimulation , 2004, European Neuropsychopharmacology.

[47]  R. D. L. Garza,et al.  A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression , 2004, Brain Research.

[48]  F. Dautzenberg,et al.  Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant , 2004, Regulatory Peptides.

[49]  Y. Taché,et al.  Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice , 2004, The Journal of physiology.

[50]  W. Vale,et al.  CRF and CRF receptors: role in stress responsivity and other behaviors. , 2004, Annual review of pharmacology and toxicology.

[51]  M. Schmidt,et al.  The Dynamics of the Hypothalamic‐Pituitary‐Adrenal Axis During Maternal Deprivation , 2004, Journal of neuroendocrinology.

[52]  M. Oitzl,et al.  Facilitation of Feedback Inhibition Through Blockade of Glucocorticoid Receptors in the Hippocampus , 1997, Neurochemical Research.

[53]  G. Alheid,et al.  CHAPTER 19 – Amygdala and Extended Amygdala of the Rat: A Cytoarchitectonical, Fibroarchitectonical, and Chemoarchitectonical Survey , 2004 .

[54]  J. Haller,et al.  Gender-specific effect of maternal deprivation on anxiety and corticotropin-releasing hormone mRNA expression in rats , 2003, Brain Research Bulletin.

[55]  G. Koob,et al.  Nibbling at CRF receptor control of feeding and gastrocolonic motility. , 2003, Trends in pharmacological sciences.

[56]  W. Vale,et al.  Increased Depression-Like Behaviors in Corticotropin-Releasing Factor Receptor-2-Deficient Mice: Sexually Dichotomous Responses , 2003, The Journal of Neuroscience.

[57]  J. F. Lopez,et al.  Impact of Maternal Deprivation on Brain Corticotropin-Releasing Hormone Circuits: Prevention of CRH Receptor-2 mRNA Changes by Desipramine Treatment , 2003, Neuropsychopharmacology.

[58]  S. Fukudo,et al.  Colorectal distention induces hippocampal noradrenaline release in rats: an in vivo microdialysis study , 2002, Brain Research.

[59]  G. Koob,et al.  Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior , 2002, Nature Genetics.

[60]  E. Mayer,et al.  Evolving pathophysiologic models of functional gastrointestinal disorders. , 2002, Gastroenterology.

[61]  Athina Markou,et al.  Assessing antidepressant activity in rodents: recent developments and future needs. , 2002, Trends in pharmacological sciences.

[62]  I. Lucki,et al.  Amplified behavioral and endocrine responses to forced swim stress in the Wistar–Kyoto rat , 2002, Psychoneuroendocrinology.

[63]  E. Lai.  Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation , 2002, Nature Genetics.

[64]  F. Holsboer,et al.  Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. , 2002, Current opinion in pharmacology.

[65]  C. Flachskamm,et al.  Corticotropin-releasing hormone receptor type 1-deficiency enhances hippocampal serotonergic neurotransmission: an in vivo microdialysis study in mutant mice , 2002, Neuroscience.

[66]  G. Koob,et al.  Mice Deficient for Both Corticotropin-Releasing Factor Receptor 1 (CRFR1) and CRFR2 Have an Impaired Stress Response and Display Sexually Dichotomous Anxiety-Like Behavior , 2002, The Journal of Neuroscience.

[67]  L. Solberg,et al.  Altered hormone levels and circadian rhythm of activity in the WKY rat, a putative animal model of depression. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[68]  L. Bourgeais,et al.  Projections from the nociceptive area of the central nucleus of the amygdala to the forebrain: a PHA‐L study in the rat , 2001, The European journal of neuroscience.

[69]  M. Oitzl,et al.  Differential and Age‐Dependent Effects of Maternal Deprivation on the Hypothalamic‐Pituitary‐Adrenal Axis of Brown Norway Rats from Youth to Senescence , 2001, Journal of neuroendocrinology.

[70]  C. Donaldson,et al.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[71]  L. Takahashi,et al.  Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety , 2001, Brain Research.

[72]  A. Hsueh,et al.  Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor , 2001, Nature Medicine.

[73]  M. Fujimiya,et al.  Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[74]  J. Vaughan,et al.  Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[75]  P. Sawchenko,et al.  Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse , 2000, The Journal of comparative neurology.

[76]  P. Matthews,et al.  Learning about pain: the neural substrate of the prediction error for aversive events. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Beverley,et al.  Evidence for visceral hypersensitivity in high-anxiety rats , 2000, Physiology & Behavior.

[78]  Paul E. Sawchenko,et al.  Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress , 2000, Nature Genetics.

[79]  Susan E. Murray,et al.  Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 , 2000, Nature Genetics.

[80]  Shakti Sharma,et al.  The Effects of Early Rearing Environment on the Development of GABAA and Central Benzodiazepine Receptor Levels and Novelty-Induced Fearfulness in the Rat , 2000, Neuropsychopharmacology.

[81]  K. Rice,et al.  Effects of Corticotropin-Releasing Factor on Neuronal Activity in the Serotonergic Dorsal Raphe Nucleus , 2000, Neuropsychopharmacology.

[82]  I. Lucki,et al.  Strain Differences in the Behavioral Effects of Antidepressant Drugs in the Rat Forced Swimming Test , 1997, Neuropsychopharmacology.

[83]  E. D. de Kloet,et al.  Stress in the brain. , 2000, European journal of pharmacology.

[84]  Michael Davis,et al.  The amygdala , 2000, Current Biology.

[85]  N. Ling,et al.  Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain , 1999, Neuroscience.

[86]  A. Shekhar,et al.  Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses , 1999, Behavioural Brain Research.

[87]  J. Jhamandas,et al.  Hypertensive rats exhibit heightened expression of corticotropin-releasing factor in activated central neurons in response to restraint stress. , 1999, Brain research. Molecular brain research.

[88]  C. Ehlers,et al.  Neurophysiological effects of intracerebroventricular administration of urocortin , 1999, Peptides.

[89]  M. Sugai,et al.  Effect of the Growth Rate of Pseudomonas aeruginosa Biofilms on the Susceptibility to Antimicrobial Agents: β-Lactams and Fluoroquinolones , 1999, Chemotherapy.

[90]  C. Nemeroff,et al.  The role of corticotropin-releasing factor in depression and anxiety disorders. , 1999, The Journal of endocrinology.

[91]  R. Rezzani,et al.  Expression of Fos immunoreactivity in the rat supraspinal regions following noxious visceral stimulation , 1998, Brain Research Bulletin.

[92]  T. Yoshimoto,et al.  Stress‐Induced Changes of Gene Expression in the Paraventricular Nucleus are Enhanced in Spontaneously Hypertensive Rats , 1998, Journal of neuroendocrinology.

[93]  I. Lucki,et al.  Effects of Corticotropin-Releasing Factor on Brain Serotonergic Activity , 1998, Neuropsychopharmacology.

[94]  G. Koob,et al.  Corticotropin Releasing Factor Receptor 1–Deficient Mice Display Decreased Anxiety, Impaired Stress Response, and Aberrant Neuroendocrine Development , 1998, Neuron.

[95]  A. Arimura,et al.  Distribution of urocortin‐like immunoreactivity in the central nervous system of the rat , 1998, The Journal of comparative neurology.

[96]  E. Vizi,et al.  Neurochemistry and pharmacology of the major hippocampal transmitter systems: Synaptic and nonsynaptic interactions , 1998, Hippocampus.

[97]  Anthony K. P. Jones,et al.  Pain processing during three levels of noxious stimulation produces differential patterns of central activity , 1997, Pain.

[98]  Gavin Kilpatrick,et al.  Urocortin, a novel neuropeptide with anxiogenic‐like properties , 1997, Neuroreport.

[99]  A. Armario,et al.  Brain corticotropin-releasing factor immunoreactivity and receptors in five inbred rat strains: relationship to forced swimming behaviour , 1997, Brain Research.

[100]  G. Koob,et al.  Appetite-Suppressing Effects of Urocortin, a CRF-Related Neuropeptide , 1996, Science.

[101]  C. Nemeroff,et al.  Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. , 1996, Endocrinology.

[102]  A. Armario,et al.  Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. , 1996, Neuroendocrinology.

[103]  A. Armario,et al.  Comparison of the behavioural and endocrine response to forced swimming stress in five inbred strains of rats , 1995, Psychoneuroendocrinology.

[104]  David Lovejoy,et al.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor , 1995, Nature.

[105]  E. De Souza,et al.  Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[106]  Qing-ping Wang,et al.  The dorsal raphe: An important nucleus in pain modulation , 1994, Brain Research Bulletin.

[107]  Wilfrid Jänig,et al.  Visceral nociceptors: a new world order? , 1992, Trends in Neurosciences.

[108]  H. Akil,et al.  Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression , 1992, Brain Research.

[109]  M. Davis,et al.  Lesions of the central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[110]  M. Davis,et al.  Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[111]  G. Koob,et al.  Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action , 1992, Brain Research.

[112]  W. Paré.  The performance of WKY rats on three tests of emotional behavior , 1992, Physiology & Behavior.

[113]  R. Sapolsky,et al.  The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. , 1991, Endocrine reviews.

[114]  S. Foote,et al.  Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons. , 1987, Neuroendocrinology.

[115]  G. Paxinos.  The Rat nervous system , 1985 .

[116]  H. Handwerker,et al.  Differential effects of noxious and non-noxious input on neurones according to location in ventral periaqueductal grey or dorsal raphe nucleus , 1980, Brain Research.

[117]  Cathryn M. Lewis,et al.  Psychoneuroendocrinology , 1979, Pharmacology Biochemistry and Behavior.